Glow Lifetech Corp. is a biotechnology company specializing in nutraceutical and cannabinoid-based products in North America. The company boasts a strong gross margin of 62.8%, indicating effective cost management, but faces challenges with negative EBITDA and net margins, suggesting operational inefficiencies. Its high liquidity ratios (current ratio of 2.63) reflect a solid short-term financial position, yet the low market cap of $7.70M raises concerns about valuation despite the promising margins. Overall, while there are strengths in its product focus and liquidity, profitability remains a significant concern.
Loading financial metrics...
Company posted a loss of $-301K over the last year, representing 13.1% of revenue.
Exceptional revenue growth of 59.1% YoY demonstrates strong market demand and competitive positioning.
Gross margin expanded by 15.7 percentage points, indicating improved pricing power or cost efficiency.
Operating margin expanded by 89.5pp, demonstrating strong operational leverage.
Both gross margin (+15.7pp) and operating margin (+89.5pp) are expanding simultaneously, indicating the company is scaling profitably.
Exceptional gross margin of 77.6% indicates strong pricing power and competitive moat.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Biotechnology companies of a similar size
Based on 2026-Q2 (June 30, 2026)